Insider Shareholders with Direct Ownership of Regulus Therapeutics Inc. (RGLS)
This section provides a comprehensive overview of the insiders with direct ownership of Regulus Therapeutics Inc. (RGLS). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Regulus Therapeutics Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Growth Equity Opportunities V, Llc
> 10% Shareholder |
4,398,602 | 0 | 6,451,056 $7.93 Million | 1 |
Dec 04, 2020
Added 40.54%
|
| 3,487,948 | 0 | 978,388 $1.2 Million | 4 |
Mar 14, 2024
Added 20.35%
|
|
|
Joseph P Hagan
Chief Executive Officer |
486,600 | 156,058 | 210,808 $259,293 | 10 |
Jan 14, 2025
Reduced 5.29%
|
|
Denis Drygin
Chief Scientific Officer |
100,000 | 0 | 100,000 $123,000 | 2 |
Mar 01, 2022
Added 43.4%
|
|
Christopher Ray Aker
Sr. VP & General Counsel |
95,375 | 51,667 | 49,546 $60,941 | 8 |
Jan 14, 2025
Reduced 9.31%
|
|
Crispina Calsada
Chief Financial Officer |
94,750 | 49,272 | 45,478 $55,937 | 5 |
Jan 14, 2025
Reduced 10.06%
|
|
Preston Klassen
President & Head of R & D |
67,500 | 31,445 | 36,055 $44,347 | 2 |
Jan 13, 2025
Reduced 46.59%
|
| 4,000 | 0 | 6,740 $8,290 | 1 |
Jul 25, 2024
Added 37.24%
|